We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Congressmen Question FDA’s Due Diligence, Request Ranbaxy Inspection Documents
Congressmen Question FDA’s Due Diligence, Request Ranbaxy Inspection Documents
July 25, 2008
Two congressmen have launched an investigation into whether the FDA allowed drugs made by Ranbaxy to be sold in the U.S. despite knowing it had approved them based on fraudulent information and were made in violation of good manufacturing practices.